NEW YORK (TheStreet) -- RATINGS CHANGES
(AMZN - Get Report) was upgraded at Argus to buy from hold. Twelve-month price target is $480. Recent pullback has created a favorable entry point.
(CREE) was upgraded at Needham to buy from hold. Twelve-month price target is $64. Company should benefit from higher demand for LED lighting, Needham said.
(EVK) was downgraded to hold at TheStreet Ratings.
(FDO) was upgraded at Sterne Agee to neutral from underperform. Valuation call, based on a 12-month price target of $55, Sterne Agee said.
was upgraded at Nomura to neutral. Twelve-month price target is $49. Backlog is improving and the company offers a 4% dividend yield, Nomura said.
was upgraded at Goldman Sachs to neutral from sell. Twelve-month price target is $88. Earnings growth appears poised to reaccelerate, Goldman Sachs said.
was upgraded at Argus to buy from hold. Twelve-month price target is $10. Company has expanded its route network and is finding ways to boost revenue, Argus said.
was upgraded at Barclays to overweight from equal-weight. Based on increased confidence in company's ability to generate strong earnings growth and good ROE, Barclays said. Twelve-month price target is $59.
was upgraded at Morgan Stanley to overweight from underweight. Twelve-month price target is $16. Natural gas market should see meaningful secular growth and the company can gain market share, Morgan Stanley said.
Reinsurance Group of America
was downgraded at Barclays to equal-weight from overweight. Driven by increased competition and low expectations of EPS growth, Barclays said. Twelve-month price target is $81.
was upgraded at Sterne Agee to buy from neutral. Twelve-month price target is $25. Company should see higher sales and margins in the coming quarters, Sterne Agee said.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts